Literature DB >> 19846841

Lost in transmission--FDA drug information that never reaches clinicians.

Lisa M Schwartz1, Steven Woloshin.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19846841     DOI： 10.1056/NEJMp0907708

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  12 in total

1.  Clinical relevance of information in the Summaries of Product Characteristics for dose adjustment in renal impairment.

Authors:  Teresa M Salgado; Blanca Arguello; Fernando Martinez-Martinez; Shalom I Benrimoj; Fernando Fernandez-Llimos
Journal:  Eur J Clin Pharmacol       Date:  2013-07-25       Impact factor: 2.953

2.  The Drug Facts Box: Improving the communication of prescription drug information.

Authors:  Lisa M Schwartz; Steven Woloshin
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-13       Impact factor: 11.205

3.  Different black box warning labeling for same-class drugs.

Authors:  Orestis A Panagiotou; Despina G Contopoulos-Ioannidis; Panagiotis N Papanikolaou; Evangelia E Ntzani; John P A Ioannidis
Journal:  J Gen Intern Med       Date:  2011-02-01       Impact factor: 5.128

4.  Getting to better prescription drug information.

Authors:  Steven Woloshin; Lisa M Schwartz
Journal:  J Gen Intern Med       Date:  2012-12       Impact factor: 5.128

5.  Eszopiclone-induced Parasomnia with Suicide Attempt: A Case Report.

Authors:  J Gibson Pennington; Jeffrey Guina
Journal:  Innov Clin Neurosci       Date:  2016-10-01

Review 6.  Improving Medication Adherence in Cardiometabolic Disease: Practical and Regulatory Implications.

Authors:  Keith C Ferdinand; Fortunato Fred Senatore; Helene Clayton-Jeter; Dennis R Cryer; John C Lewin; Samar A Nasser; Mona Fiuzat; Robert M Califf
Journal:  J Am Coll Cardiol       Date:  2017-01-31       Impact factor: 24.094

Review 7.  A plea for a more epidemiological and patient-oriented pharmacovigilance.

Authors:  Veronica Scurti; Marilena Romero; Gianni Tognoni
Journal:  Eur J Clin Pharmacol       Date:  2011-07-20       Impact factor: 2.953

8.  Physicians' use of and preferences for FDA-approved prescribing information.

Authors:  Helen W Sullivan; Claudia Squire; Kathryn J Aikin; Janice Tzeng; Kate Ferriola-Bruckenstein; Eric Brodsky; Ann Marie Trentacosti; Mihaela Johnson
Journal:  Res Social Adm Pharm       Date:  2021-08-01

9.  Information on new drugs at market entry: retrospective analysis of health technology assessment reports versus regulatory reports, journal publications, and registry reports.

Authors:  Michael Köhler; Susanne Haag; Katharina Biester; Anne Catharina Brockhaus; Natalie McGauran; Ulrich Grouven; Heike Kölsch; Ulrike Seay; Helmut Hörn; Gregor Moritz; Kerstin Staeck; Beate Wieseler
Journal:  BMJ       Date:  2015-02-26

10.  Long term effectiveness on prescribing of two multifaceted educational interventions: results of two large scale randomized cluster trials.

Authors:  Nicola Magrini; Giulio Formoso; Oreste Capelli; Emilio Maestri; Francesco Nonino; Barbara Paltrinieri; Cinzia Del Giovane; Claudio Voci; Lucia Magnano; Lisa Daya; Anna Maria Marata
Journal:  PLoS One       Date:  2014-10-17       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.